Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I expect returned shares to be over 300 million based on numbers I have seen. Disbursement is the term I think.
The part about the sales people asking for health and beauty products to sell in place of foods for now is significant. These people probably get paid partly on commission and they know what they are talking about I would think as they are out there talking to people. That is a very BOLD statement by Hagen that they will beat 2018 revs. Q3 is make or break IMO. I give him a pass on being blindsided by the FDA indecisiveness, I was too and I am in the field of supplement research.
I REALLY like this part of Hagen's letter about the salesforce and sales by Sept 30
Entry into the “Health and Beauty” Market
As I write this letter, Diamond CBD is finalizing preparations for the market introductions of several new lines of topical products into several segments of the multi-billion dollar U.S. “health and beauty” market, including cosmetics, shampoos and hair conditioners. Entering these market segments will be a new, exciting experience for us that will put us into different and various consumer channels of distribution. Furthermore, our current distributors have already expressed strong interest in providing these new lines for their resellers.
By September 30th, as a result of the introduction of these new product lines, we expect that we will have erased the mid-year revenue variance from the year-to-year comparison, and jump ahead of our historic sales figures. In addition, remember that third quarter and fourth quarter revenues for us have historically always been strong, so we anticipate finishing 2019 by exceeding 2018’s $25.5 million in revenue by a meaningful margin.
https://www.businesswire.com/news/home/20190826005293/en/PotNetwork-Holdings%E2%80%99-CEO-Kevin-Hagen-Issues-Mid-Year
Shares dropped yesterday because of this hack job calling Vaccaro president.
https://m.benzinga.com/article/14368600?utm_referrer=https%3A%2F%2Fwww.benzinga.com%2Fcannabis%2F&utm_source=https%3A%2F%2Fwww.benzinga.com%2Fcannabis%2F
POTN now has loans instead of toxic debt, growing margins and earnings, SEC registered shares, uplist coming any day. Probably hundreds of millions of shares to be retired from criminal shareholders in about a month- just revenues are in question. The CEO says revs are on track for 25 million this year or greater. Looks good to me if the revenue target is hit with a market cap to rev multiple on ONLY ONE!
These disclosures are required for uplisting to the OTCQB market. It's possible that we see the CE removed this week which would allow uplisting, certainly a catalyst to boost shareprice.
My memory is that Illiad shares mature in 2020 and can be sold when POTN reached .45. This could just as easily mean that Hagen is expecting to hit greater than .45 by January.
A CBD stock with similar market cap on OTCPINK that has little to no revenues just doubled its shares outstanding and had little change in share price- FRLF. There is no reason to expect POTN to go lower, already at rock bottom 1X revenues.
Agree, that would go a long way toward building credibility while waiting for the FDA to finally move on regulations. The video below explains how ridiculous the FDA has been about CBD regulations. This CEO could be talking about POTN, same problems same strategy going forward.
If that was true you could post a link and a page number in a disclosure.
Let's say management was involved. They would have been arrested weeks ago with the rest. The FBI undercover agents conducted the criminal activity with Vaccaro until they could ID all involved. I'm sure Vaccaro has squealed on anything that would lighten his sentence. Vacarro and others told the undercover agents NOT to tell the CEO.
Retailers like POTN will be first to make money in this industry.
Elinor Taieb is a woman isn't she?
If they hit their revenue projection of 26 million or greater and increase margins and earnings as stated in the letter from the CEO a few days ago, .25 to .50 if market sentiment improves. This is a top 10 retailer in the fastest growing industry.
Clinical data looks good for sleep and anxiety treatment by CBD, it's proven to not be addictive or have side effects, and the FDA is making some decisions to be announced any day. IMO POTN will be right back on top if they allow certain foods and beverages with warning labels. At that time national chains will carry CBD products also. I can imagine CBD cake pops in your grocery store chain.
The trial is a few weeks away, they will be convicted.
Thanks for the info, I had been concerned that someone in the company in the marketing area was informing Vaccaro about the timing of PRs, that makes sense and further explains the CE.
POTN is fully SEC reporting, the major requirement for uplist. Now they need the CE removed to uplist, and I don't know what that requires except that the one month minimum time length is up next week.
Hagen said in his recent letter that he is still expecting to uplist.
The CE stays on for one month minimum. The CEO has filed several disclosures during this time and I would expect that Hagen has been communicating with the OTC market to provide any legal documents required to get it removed asap. These are my assumptions, I don't know what is required for CE removal. If the shares in question have been removed from trading by the criminal owners and the company has provided proof that they are in no way involved, I assume the CE can be removed.
I am happy to see that interest is still high enough to generate 1-4 million in volume each day, but I am sure looking forward to most of it being upside volume with positive news or a change of sentiment for the whole sector.
King of sales
DiamondCBD was kind of sales in edibles. Who knows, if FDA allows edibles with warning labels, they could very quickly be the leader again since they have national branding and production in place. And in the best case of national distribution by amazon and pharmacies, revs could increase rapidly.
So here is the question- is CBD recession proof?
In comparison to a few months ago, these are all huge plusses. If we knew then that all holders of toxic debt were arrested and likely to lose their shares (or worst case be forced to sell them back at .003 I speculate), POTN is on track to beat 25 million in revs this year, margins are better and earnings will be higher, POTN is SEC reporting and will be listed OTCQB soon....
And all this at a market cap = revenues!
Losing the CE and uplisting to OTCQB is likely to be the next catalyst, looking for it next week. I believe Sept 2 is the one month mark for the CE showing up following the arrest of Vaccaro.
CE could come off next week with uplist soon to follow. Sept 20 is criminal trial, we could get a filing on share reduction around then. And the FDA might get off their high horse and put out some clarity of regulation of CBD foods within the month.
The uplist and revenues will soon drive the share price to a reasonable level in spite of the general market turmoil, IMO. Many positive catalysts are coming soon.
The market cap of POTN is lower than 2019 projected earnings, ridiculous! There is a very fast 5X profit to be made here by Q3 earnings IMO. I expect a substantial cut in outstanding shares (hundreds of millions that belong to criminals with the upcoming trial Sept 20), a jump in revs from new non-food products, and when the FDA finally gets it together soon a national distribution partner of favorite CBD foods. The downside- it's an uphill battle against the toxic, zero strategy trade wars and threat of recession. When the CE comes off soon and revs jump back up, uncertainty will be over.
I am VERY reassured by Hagen's letter, and it tells me that we can confidently expect POTN to catch up revenues with the new lines for hair and beauty that will be marketed by the salesforce already in place.
They won't make Diamond take them off the market or web siteI don't think, they have been selling for a long time. But big national pharmacies probably won't be selling edibles until the FDA makes a decision. IMO Diamond really had a competitive advantage with their well branded edibles.
The inept handling of CBD regulations by the FDA infuriates me. As a general rule, natural plant-derived compounds that have been consumed by humans and are available on the market are considered GRAS, generally recognized as safe. CBD has been proven in clinical trials to be non addictive. They have made up new, stricter rules for a compound consumed for thousands of years and really hurt companies like POTN.
CBD is a group of compounds that as a whole, have strong anti-inflammatory properties and can treat many conditions. Research is ongoing. A similar example is that Curcumin can reverse alopecia, baldness in spots, when rubbed on the spot. I was impresses last year when Goulding's biomed tech line combined CBD and Curcumin in capsules which would be a treatment for cancer and arthritis, among others.
If you read the last filing, you will see the crypto mining subsidiary listed. Mark Zuckerberg owns millions of shares of Facebook too, why is that a problem? The owner of the greatest number of shares has the biggest incentive to maximize share price.
So 30 day CE goes away and possible uplist very soon following? Could be next week- THAT would be a catalyst to move up.
Sales force will make it happen in their established channels. I had suspected the FDA scewed up DiamondCBDs great revs from food products, now we know it's true.
The most important statement in Hagen's letter to shareholders today bears repeating.
"we anticipate finishing 2019 by exceeding 2018’s $25.5 million in revenue by a meaningful margin. "
Within a few months, banking will be approved for MJ and CBD and FDA regulations will be released, and both will be general catalysts. We really need to see some action by Hagen on a deal that will ramp up sales, that will make the share price ignite. Last year Hagen said he was in talks with national pharmacies. I am thrilled to see DiamondCBD on Amazon now.
Yes there are many, but few have 20-30 million in revenues with a market cap of 1-1.5 revs, the potential to cancel debt and cancel 25% of shares. The downside from what we know now is that 2 large shareholders were using their shares for criminal activity.